| Dr Robin Patrick Spradling, DO | |
|
3600 Nw Samaritan Dr, Corvallis, OR 97330-3737 | |
| (541) 768-4906 | |
| Not Available |
| Full Name | Dr Robin Patrick Spradling |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 3600 Nw Samaritan Dr, Corvallis, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427312487 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | PG158899 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robin Patrick Spradling, DO 6298 Sw Grand Oaks Drive, Building I Unit #301, Corvallis, OR 97333 Ph: (702) 217-6292 | Dr Robin Patrick Spradling, DO 3600 Nw Samaritan Dr, Corvallis, OR 97330-3737 Ph: (541) 768-4906 |
News Archive
In the first comprehensive study to look at how anti-smoking laws are affecting the health of children, researchers from University of Edinburgh collaborated with researchers from Maastricht University, Hasselt University, Harvard Medical School and Brigham and Women's Hospital, to conduct a systematic review and meta-analysis examining the effect of smoke-free legislation on child health.
CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients' own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease.
A special newly discovered biomarker, "Gb3," potentially related to the survival of heart disease patients, could change the way the country's No. 1 killer is monitored in the future, according to research published in the Feb. 4 edition of the Journal of the American Heart Association.
Flood water samples taken by the U.S. Environmental Protection Agency within the city limits of Des Moines, Cedar Rapids, Hamburg, and Burlington, Iowa, showed numbers of fecal coliform bacteria exceeding the health-based level of concern. The level of concern is 200 colony forming units (cfu) per 100 milliliters (ml).
The pathogenesis of chronic hepatitis C is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect. Two previous clinical studies have reported that the Viusid related effect on histologic features, especially fibrosis, appears to be associated with antioxidant and/or immunomodulatory properties.
› Verified 7 days ago
Mr. Harry Steven Oxenhandler, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2727 Nw 9th Street, Corvallis, OR 97330 Phone: 541-757-8970 Fax: 541-757-8250 | |
Dr. Elizabeth Figa, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Dr. Christine Elizabeth Rivers, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1278 | |
Dr. Tessa Rhea Maggiulli, DVM General Practice Medicare: Not Enrolled in Medicare Practice Location: 1562 Sw 3rd St, Corvallis, OR 97333 Phone: 541-753-2223 Fax: 541-753-2278 | |
Christopher William Leesman, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 3600 Nw Samaritan Dr, Graduate Medical Education, Good Samaritan Hospital, Corvallis, OR 97330 Phone: 541-768-6909 |